首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1085808

嗅覺障礙的全球市場：按類型、治療、區域規模、份額、前景、機會分析（2022-2028 年）

Anosmia Market, by Type, by Treatment (Therapies and Medications ), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年05月10日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

嗅覺障礙病例的增加是預計在預測區間內推動全球嗅覺障礙市場增長的主要因素。此外，市場公司正專注於旨在提供治療嗅覺障礙的新產品的研發活動，預計這將在預測期內推動市場增長。

本報告研究和分析全球失眠症市場，並提供市場概況、市場動態、趨勢、競爭形勢和企業概況等系統信息。

Anosmia, the clinical term for the inability to smell. This disorder impair the ability to sense odors in the environment, as well as hinder the quality of life related to social interactions, eating, and feelings of well-being. It is a severe disability, affected genetically or accidentally, resulting in total/partial absence of olfactory guidance.

Market Dynamics

Rising anosmia cases is the major factor that is expected to drive growth of the global anosmia market during the forecast period. For instance, according to an article published by the National Institute on Deafness and Other Communication Disorders in February 2021, around 3% of U.S. populace have anosmia i.e.no sense of smell.

Market players are focusing on research and development activities for offering novel products for the treatment anosmia, which is expected to drive the market growth over the forecast period. For instance, in July 2020, Zydus Cadila received the U.S. Food & Drug Administration (U.S. FDA) approval for its supplemental abbreviated new drug application (SANDA) for Doxycycline Injection USP, 100 mg/vial, which seems to improve respiratory symptoms and anosmia

Key features of the study:

This report provides in-depth analysis of the global anosmia market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global anosmia market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Mylan N.V., Pfizer Inc., Atom Pharma, RANBAXY LABORATORIES LIMITED, Alde Medi Impex, GlaxoSmithkline plc, Sandoz (Novasrtis AG), Inke S.A., Taj Pharmaceuticals Limited, and Sanofi, amongst others.
Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global anosmia market report caters to various stakeholders in this industry including investors, suppliers, anosmia manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global anosmia market.

Detailed Segmentation

Global Anosmia Market, By Type

Idiopathic Anosmia
Congenital Anosmia

Global Anosmia Market, By Treatment

Therapies
Nasal Endoscopy
Imaging
Medications
Decongestants
Antihistamines
Steroid Nasal Sprays

Global Anosmia Market, By Region

North America
By Country
U.S.
Canada
By Type
Idiopathic Anosmia
Congenital Anosmia
By Treatment
Therapies
Nasal Endoscopy
Imaging
Medications
Decongestants
Antihistamines
Steroid Nasal Sprays
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Type
Idiopathic Anosmia
Congenital Anosmia
By Treatment
Therapies
Nasal Endoscopy
Imaging
Medications
Decongestants
Antihistamines
Steroid Nasal Sprays
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Type
Idiopathic Anosmia
Congenital Anosmia
By Treatment
Therapies
Nasal Endoscopy
Imaging
Medications
Decongestants
Antihistamines
Steroid Nasal Sprays
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Type
Idiopathic Anosmia
Congenital Anosmia
By Treatment
Therapies
Nasal Endoscopy
Imaging
Medications
Decongestants
Antihistamines
Steroid Nasal Sprays
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Type
Idiopathic Anosmia
Congenital Anosmia
By Treatment
Therapies
Nasal Endoscopy
Imaging
Medications
Decongestants
Antihistamines
Steroid Nasal Sprays
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Type
Idiopathic Anosmia
Congenital Anosmia
By Treatment
Therapies
Nasal Endoscopy
Imaging
Medications
Decongestants
Antihistamines
Steroid Nasal Sprays
Company Profiles
Mylan N.V.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Pfizer Inc.
Atom Pharma
RANBAXY LABORATORIES LIMITED
Alde Medi Impex
GlaxoSmithkline plc
Sandoz (Novasrtis AG)
Inke S.A.
Taj Pharmaceuticals Limited
Sanofi

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By Treatment
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Key Highlights
Product Pipeline
Regulatory Scenario
Product launch/Approvals
PEST Analysis
Merger and Acquisition Scenario
Market Share Analysis

4. Global Anosmia Market - Impact of Coronavirus (Covid-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
COVID-19 Impact on the Anosmia

5. Global Anosmia Market, By Type, 2017 - 2028 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Idiopathic Anosmia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Congenital Anosmia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Anosmia Market, By Treatment, 2017 - 2028 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Nasal Endoscopy
- Imaging
Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Decongestants
- Antihistamines
- Steroid Nasal Sprays

7. Global Anosmia Market, By Region, 2017 - 2028 (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- Regional Trends
North America
- Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa

8. Competitive Landscape

Heat Map Analysis
Company Profiles
- Mylan N.V.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Atom Pharma
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- RANBAXY LABORATORIES LIMITED
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Alde Medi Impex
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GlaxoSmithkline plc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sandoz (Novasrtis AG)
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Inke S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Taj Pharmaceuticals Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sanofi
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
Analyst Views

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

嗅覺障礙的全球市場：按類型、治療、區域規模、份額、前景、機會分析（2022-2028 年）

Anosmia Market, by Type, by Treatment (Therapies and Medications ), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目錄

第 1 章調查目標/先決條件

第二章市場概述

第三章市場動態/監管/趨勢分析

第 4 章全球嗅覺障礙市場：冠狀病毒 (COVID-19) 大流行的影響

第 5 章全球失眠症市場：按類型 (2017-2028)

第 6 章全球嗅覺障礙市場：按治療 (2017-2028)

第 7 章全球失眠症市場：按地區（2017-2028 年）

第8章競爭態勢

第9章章節

Market Dynamics

Key features of the study:

Detailed Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Anosmia Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Anosmia Market, By Type, 2017 - 2028 (US$ Million)

6. Global Anosmia Market, By Treatment, 2017 - 2028 (US$ Million)

7. Global Anosmia Market, By Region, 2017 - 2028 (US$ Million)

8. Competitive Landscape

9. Section

嗅覺障礙的全球市場：按類型、治療、區域規模、份額、前景、機會分析（2022-2028 年）

Anosmia Market, by Type, by Treatment (Therapies and Medications ), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目錄

第 1 章調查目標/先決條件

第二章市場概述

第三章市場動態/監管/趨勢分析

第 4 章全球嗅覺障礙市場：冠狀病毒 (COVID-19) 大流行的影響

第 5 章全球失眠症市場：按類型 (2017-2028)

第 6 章全球嗅覺障礙市場：按治療 (2017-2028)

第 7 章全球失眠症市場：按地區（2017-2028 年）

第8章競爭態勢

第9章 章節

Market Dynamics

Key features of the study:

Detailed Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Anosmia Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Anosmia Market, By Type, 2017 - 2028 (US$ Million)

6. Global Anosmia Market, By Treatment, 2017 - 2028 (US$ Million)

7. Global Anosmia Market, By Region, 2017 - 2028 (US$ Million)

8. Competitive Landscape

9. Section

第9章章節